Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new site revision entry Revision: v3.3.3 was added. The items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check46 days agoChange DetectedThe Record History shows an addition of Revision: v3.3.2 and a deletion of Revision: v3.3.1 in the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded a new history entry: Revision v3.3.1. The previous Revision v3.2.0 entry has been removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding notice/banner about operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check74 days agoChange DetectedThe history shows multiple updates to study status and recruitment status across versions, reflecting changes in trial activity and enrollment over time.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.